Skip to main content

Why Jim Cramer's 'Upset With the FDA'

Publish date:
Video Rating:
Video Duration:

Pfizer  (PFE)  and BioNTech's  (BNTX)  vaccine candidate faces a committee convened with the FDA today. 

The FDA's 17-member Vaccines and Related Biological Products Advisory Committee, or VRBPAC, will meet Thursday to discuss Pfizer and German partner BioNTech’s vaccine candidate and they will then vote on whether or not the FDA should authorize the shot.

The FDA, while it isn't required to follow the committee's recommendation, often does. The FDA will convene following the panel to make an official decision on the vaccine. So far, the United Kingdom and Canada have authorized the vaccine.

Cramer expressed frustration with the FDA's timeline for emergency authorization. "I think it’s really bad that Canada started doing this before we did... a week is a lot of [deaths]." 

WATCH: Everything Jim Cramer Is Watching in the Market Thursday

Latest Videos From TheStreet and Jim Cramer:

Related Videos